Wednesday, February 08, 2017 1:13:24 AM
10mln upfront for Rexista is now considered high end. Well we will probably get shorted bravely with that number.
When you speak profit you hear costs.
And then Ipci has nothing hot...oxy issues are already solved.
So no surprise. As sadly wrote back I see the buyout as the only wayout.
When FDA blocked Focalin we made -25?, when ipci announced par starting to deliver the new doses...Nothing or sglightly negative...We already knew I read.
Every position is legitimate, absolutely. But this stock is going to do good all at once, exactly because each event is a non event, or a mild event or a positive with more negatives. So why invest in ipci? Looking a growth company through P/e lenses?
And do not forget the Group which is controlling the price since and will keep on doing it.
Hope for the buyout to come after next 2 Andas approved and before Rexista approval.
Jmho
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM